Table II.
Univariate (Log-rank) | Multivariate | ||||
---|---|---|---|---|---|
Clinicopathological factors | 5-year DSS (%) | P-value | HR | 95% CI | P-value |
Age | |||||
≥70 years | 67 | 0.100 | |||
<70 years | 75.5 | ||||
Sex | |||||
Male | 75.6 | 0.878 | |||
Female | 67.1 | ||||
Location | |||||
L, M | 76.5 | 0.020 | 1 | 0.029 | |
U | 58.1 | 1.74 | 1.06–2.85 | ||
Pathological type | |||||
Differentiated | 81.6 | 0.003 | 1 | 0.447 | |
Undifferentiated | 65 | 1.21 | 0.74–2.00 | ||
Depth of invasion | |||||
T1 | 97.3 | <0.001 | 1 | <0.001 | |
T2/T3/T4 | 64.7 | 6.60 | 2.29–18.99 | ||
Lymph node metastasis | |||||
Negative (N0) | 94.2 | <0.001 | 1 | <0.001 | |
Positive (N1/2/3) | 57.5 | 5.26 | 2.51–11.04 | ||
Distant metastasis | |||||
Negative | 79.4 | <0.001 | 1 | <0.001 | |
Positive | 0.0 | 5.79 | 3.42–9.81 | ||
PAK5 | |||||
Low | 74.8 | 0.014 | 1 | 0.659 | |
High | 58 | 1.14 | 0.65–2.00 |
DSS, disease specific survival; PAK5, P21-activated kinase 5; HR, hazard ratio; CI, confidence interval. L, lower third of the stomach; M, middle third of the stomach; U, upper third of the stomach.